Literature DB >> 2351122

Toxicity of styrene vapor in hepatocyte monolayers at low oxygen tensions.

A K Costa1, J R Trudell.   

Abstract

Hepatocyte monolayer cultures were exposed to 6000 ppm styrene vapor at 20%, 2%, or 1% O2 and assayed for signs of cell damage immediately following the 2-hr exposure and then 24 hr later. Oxygen concentrations were used that were previously shown to maximize lipid peroxidation and to predispose hepatocyte monolayers to chemical injury. The use of two time points allowed assessment of acute injury as well as injury that requires several hours to manifest itself. The uptake of styrene into the buffer in the culture dishes was measured by gas chromatography and was found to be 0.49, 0.68, and 0.74 mM at 15, 60, and 120 min, respectively. However, as measured by release of aspartate aminotransferase and inclusion of trypan blue, no toxicity was evident at either time point, irrespective of the oxygen concentration. This study shows that despite the weakening of hepatocyte defense mechanisms by hypoxia, styrene is not acutely toxic to these cells. Furthermore, if any damage to DNA, RNA, or the capability for protein synthesis occurs during exposure to styrene, it is insufficient to cause lysis within 24 hr.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351122      PMCID: PMC1567641          DOI: 10.1289/ehp.9084209

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  23 in total

1.  Metabolism and mutagenicity of styrene.

Authors:  T Watabe; M Isobe; T Sawahata; K Yoshikawa; S Yamada; E Takabatake
Journal:  Scand J Work Environ Health       Date:  1978       Impact factor: 5.024

Review 2.  Phenotypic stability of adult rat hepatocytes in primary monolayer culture.

Authors:  D M Bissell; P S Guzelian
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

3.  Nutrient imbalance causes the loss of cytochrome P-450 in liver cell culture: formulation of culture media which maintain cytochrome P-450 at in vivo concentrations.

Authors:  A J Paine; L J Hockin
Journal:  Biochem Pharmacol       Date:  1980-12-01       Impact factor: 5.858

4.  Investigation of styrene in the liver perfusion/cell culture system. No indication of styrene-7,8-oxide as the principal mutagenic metabolite produced by the intact rat liver.

Authors:  B Beije; D Jenssen
Journal:  Chem Biol Interact       Date:  1982-03-01       Impact factor: 5.192

5.  Effects of microsomal induction and inhibition on styrene-induced acute hepatotoxicity in rats.

Authors:  S Chakrabarti; J Brodeur
Journal:  J Toxicol Environ Health       Date:  1981-10

6.  Arene oxides in styrene metabolism, a new perspective in styrene toxicity?

Authors:  C Pantarotto; R Fanelli; F Bidoli; P Morazzoni; M Salmona; K Szczawinska
Journal:  Scand J Work Environ Health       Date:  1978       Impact factor: 5.024

7.  Enhancement of lipid peroxidation in rat liver on acute exposure to styrene and acrylamide a consequence of glutathione depletion.

Authors:  S P Srivastava; M Das; P K Seth
Journal:  Chem Biol Interact       Date:  1983-08-01       Impact factor: 5.192

8.  Toxicity of 1,2-dibromoethane in primary hepatocyte monolayer cultures: lack of dependence on oxygen concentration.

Authors:  A K Costa; J R Trudell
Journal:  Toxicol Appl Pharmacol       Date:  1988-09-15       Impact factor: 4.219

9.  Effects of styrene oxide on chromosome aberrations, sister chromatid exchange and hepatic drug biotransformation in chinese hamsters in vivo.

Authors:  H Norppa; E Elovaara; K Husgafvel-Pursiainen; M Sorsa; H Vainio
Journal:  Chem Biol Interact       Date:  1979-08       Impact factor: 5.192

10.  Metabolism and toxicity of styrene.

Authors:  K C Leibman
Journal:  Environ Health Perspect       Date:  1975-06       Impact factor: 9.031

View more
  1 in total

1.  Serum hepatic biochemical activity in two populations of workers exposed to styrene.

Authors:  C A Brodkin; J D Moon; J Camp; D Echeverria; C A Redlich; R A Willson; H Checkoway
Journal:  Occup Environ Med       Date:  2001-02       Impact factor: 4.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.